Platelet-rich plasma injection demonstrates long-term analgesic efficacy in patients with carpal tunnel syndrome, offering a promising nonsurgical treatment option to alleviate pain and improve functional outcomes in individuals with this common entrapment neuropathy.
September 2022
Political engagement during the Trump administration negatively impacted public health, contributing to adverse health outcomes and exacerbating health disparities, highlighting the need for evidence-based policymaking and public health interventions to mitigate the detrimental effects of political decisions on population health.
September 2022
Intimate partner violence starts early and is already prevalent in younger age groups, highlighting the urgent need for targeted prevention strategies and comprehensive support services to address this serious social problem and promote healthy relationships.
September 2022
Higher sodium and lower potassium excretion in urine are associated with increased cardiovascular risk, highlighting the importance of dietary sodium and potassium intake in modulating cardiovascular health and preventing cardiovascular diseases.
September 2022
Adopting a ketogenic diet, characterized by reduced carbohydrate intake and induction of therapeutic ketosis, demonstrates favorable and effective outcomes in managing polycystic ovary syndrome (PCOS), highlighting the potential role of dietary interventions in PCOS management.
September 2022
Social determinants such as education, income, neighborhood, and food environment significantly influence obesity rates, highlighting the complex interplay between socioeconomic factors and health outcomes and informing targeted interventions to address disparities in obesity prevalence.
September 2022
A phase III clinical trial of a vaccine based on the Omicron variant begins, aiming to evaluate different dosing regimens in adult volunteers without comorbidities and assess the vaccine's efficacy and safety for potential use as a booster dose.
September 2022
The FDA endorses the Pfizer booster vaccine for children aged 12-15 years old and authorizes an additional dose for immunocompromised children aged 5-11 years old, alongside shortened intervals for booster doses, aiming to enhance vaccine coverage and protection against COVID-19 in pediatric populations.
September 2022
Sleep deficit is associated with higher metabolic risk in women, underscoring the importance of sleep hygiene and adequate sleep duration in promoting metabolic health and preventing cardiometabolic diseases in female populations.
September 2022